Glipizide

From WikiMD's Wellness Encyclopedia

(Redirected from Glucotrol XL)

Glipizide[edit | edit source]

Introduction[edit | edit source]

Glipizide is an oral hypoglycemic medication used primarily in the management of Type 2 Diabetes. It is available as a tablet and is known under the brand name Glucotrol, manufactured by Pfizer Inc.

Overview[edit | edit source]

Glipizide is classified as a sulfonylurea, a group of medications that work by stimulating insulin secretion from the pancreatic beta cells. It is commonly prescribed in the treatment of Type 2 Diabetes when diet and exercise alone are not sufficient to control blood sugar levels.

Dosage and Administration[edit | edit source]

Glipizide 2.5mg tablet

The medication is available in a 2.5mg dosage, among others. The starting dose is typically low to minimize the risk of hypoglycemia and then gradually increased based on the patient's response.

Mechanism of Action[edit | edit source]

Glipizide works by increasing insulin production in the pancreas, which helps lower blood glucose levels. It is part of a broader treatment plan that includes diet, exercise, and possibly other medications.

Side Effects and Precautions[edit | edit source]

Common side effects of Glipizide include hypoglycemia, weight gain, and gastrointestinal issues. Patients should be aware of the signs of low blood sugar and how to manage them.

Interactions[edit | edit source]

Glipizide may interact with other medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs), other antidiabetic drugs, alcohol, and certain antibiotics. Patients should inform their healthcare provider of all medications they are taking.

See Also[edit | edit source]

References[edit | edit source]

1. Pfizer Inc - Glipizide Information 2. National Center for Biotechnology Information - Glipizide in Type 2 Diabetes Management

External Links[edit | edit source]

Glipizide Resources

Contributors: Kondreddy Naveen